Exchange: NASDAQ·Updated 12:27 PM EDT
NKTR logo

NKTR Nektar Therapeutics

$73.69
$2.68
(3.51%)
Today
Reported EarningsAug 13
Mkt Cap$2.61B
Vol166,921.00

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.
51

Neutral Sentiment

How do you feel about NKTR?

Advertisement|Remove ads.